BioLegend licensed CITE-seq and developed the TotalSeqTM-C Human Universal Cocktail v1.0, a collection of 130 oligo-linked antibodies for massive screening of the cell-surface proteins of individual cells, for use on a single-cell sequencing platform from 10X Genomics.

BioLegend

San Diego

BioLegend startup from San Diego, United States is ranked 320 out of 2449 worldwide and 120 from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map